Capmatinib: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
4
Conditions studied
49
US states with sites
2
Countries
Phase breakdown
Phase 2 1
Not applicable 1
Conditions being studied
| Condition | Trials |
|---|---|
| Lung cancer | 2 |
| Non-Small-Cell Lung Carcinoma | 1 |
| Recurrent Lung Non-Small Cell Carcinoma | 1 |
| Stage IV Lung Cancer AJCC v8 | 1 |
Recruiting trials involving Capmatinib
- A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea
- Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Common questions
How many recruiting trials involve Capmatinib?
2 recruiting trials across 4 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.